Capital Markets: Recent IPOs

Since 2009, we have been involved in 450+ public offerings including some of the nation's most notable securities transactions. Following are some recent representative offerings.

Completed IPOs

  • Underwriters in Redfin $138.5 million IPO (July 2017)
  • Akcea Therapeutics in its $143.8 million IPO (July 2017)
  • Dova Pharmaceuticals in its $86.3 million IPO (June 2017)
  • ShotSpotter in its $35.4 million IPO (June 2017)
  • Appian in its $86.3 million IPO (May 2017)
  • Underwriters in Argenx $114.7 million IPO (May 2017)
  • Ovid Therapeutics in its $75.0 million IPO (May 2017)
  • Biohaven Pharmaceuticals in its $193.6 million IPO (May 2017)
  • UroGen Pharma in its $58.2 million IPO (May 2017)
  • Underwriters in Zymeworks $58.5 million IPO (April 2017)
  • Underwriters in Verona Pharma $80.0 million IPO (April 2017)
  • Underwriters in Yext $132.8 million IPO (April 2017)
  • Tocagen in its $97.8 million IPO (April 2017)
  • Underwriters in Alteryx, Inc. $126.0 million IPO (March 2017)
  • Underwriters in Valeritas Inc. $52.5 million IPO (March 2017)
  • Underwriters in AnaptysBio $86.3 million IPO (January 2017)
  • ObSeva SA in its $96.8 million IPO (January 2017)
  • Myovant Sciences Ltd. in its $217.5 million IPO (October 2016)
  • Everspin Technologies, Inc. in its $40 million IPO (October 2016)
  • Underwriters in Tabula Rasa $59.3 million IPO (September 2016)
  • Underwriters in Apptio Inc. $110.4 million IPO (September 2016)
  • Underwriters in Novan Therapeutics $51.9 million IPO (September 2016)
  • Everbridge, Inc. in its $90 million IPO (September 2016)
  • Protagonist Therapeutics, Inc. in its $90.0 million IPO (August 2016)
  • Underwriters in Gemphire Therapeutics $30.0 million IPO (August 2016)
  • Underwriters in Audentes Therapeutics, Inc. $75.0 million IPO (July 2016)
  • Underwriters in Syros Pharmaceuticals $50.0 million IPO (June 2016)
  • Underwriters in Selecta Biosciences $70.0 million IPO (June 2016)
  • Underwriters in Nanthealth $96.6 million IPO (June 2016)
  • Clearside Biomedical, Inc. in its $50.4 million IPO (June 2016)
  • Underwriters in Merus N.V. $61.4 million IPO (May 2016)
  • Oncobiologics, Inc. in its $40.0 million IPO (May 2016)
  • MaxCyte, Inc. in its $10.0 million IPO (March 2016)
  • Senseonics Holdings, Inc. in its $49.1 million IPO (March 2016)
  • Underwriters in Syndax Pharmaceuticals, Inc. $52.8 million IPO (March 2016)
  • AveXis Inc. in its $95 million IPO (February 2016)
  • RockRose Energy plc in its $4.4 million IPO (January 2016)
  • Underwriters in Atlassian, Inc. $531.3 million IPO (December 2015)
  • Instructure, Inc. in its $70.4 million IPO (November 2015)
  • Underwriters in Wave Life Sciences $102 million IPO (November 2015)
  • Underwriters in Voyager Therapeutics, Inc. $80.5 million IPO (November 2015)
  • Underwriters in Strongbridge Biopharma $28.8 million IPO (October 2015)
  • Pure Storage, Inc. in its $425 million IPO (October 2015)
  • Aclaris Therapeutics, Inc. in its $55 million IPO (October 2015)
  • Underwriters in NantKwest, Inc. $238.3 million IPO (July 2015)
  • Rapid7, Inc. in its $118.7 million IPO (July 2015)
  • Underwriters in Ooma, Inc.$74.8 million IPO (July 2015)
  • Chiasma* in its $117.1 million IPO (July 2015)
  • Underwriters in ProNAi $158.4 million IPO (July 2015)
  • Underwriters in Fantex Jack Mewhort Series $2.7 million IPO (July 2015)
  • Alarm.com, Inc. in its $98 million IPO (June 2015)
  • Underwriters in Catabasis Pharmaceuticals, Inc. $60 million IPO (June 2015)
  • Underwriters in MINDBODY $115.1 million IPO (June 2015)
  • Underwriters in Celyad S.A. $100.1 million IPO (June 2015)
  • Axovant Sciences Ltd.     in its $362.3 million IPO (June 2015)
  • Underwriters in Fantex Michael Brockers Series $3.6 million IPO (May 2015)
  • Underwriters in Arcadia Biosciences, Inc. $68.2 million IPO (May 2015)
  • HTG Molecular Diagnostic, Inc. in its $57.7 million IPO (May 2015)
  • Underwriters in Apigee Corporation $86.96 million IPO (April 2015)
  • KemPharm, Inc. in its $$55.9  million IPO (April 2015)
  • Cidara Therapeutics, Inc. in its $88.32 million IPO (April 2015)
  • Aduro BioTech, Inc. in its $119 million IPO (April 2015)
  • SteadyMed Ltd. in its $40 million IPO (March 2015)
  • Underwritesr in Fantex Alshon Jeffery Series $8.4 million IPO (March 2015)
  • Underwriters in Inotek Pharmaceuticals Corporation $40 million IPO (February 2015)
  • Underwriters in Invitae Corporation $116.8 million IPO (February 2015)
  • Underwriters in Nextvet Biopharma plc $40 million IPO (February 2015)
  • TRACON Pharmaceuticals in its $36 million IPO (January 2015)
  • FlexPharma, Inc. in its $86.4 million IPO (January 2015)
  • Underwriters in Ascendis Pharma $108 million IPO (January 2015)
Related Practices & Industries

Capital Markets